Next Article in Journal
Identification, Isolation, and Characterization of a New Degradation Impurity in Nafcillin Sodium
Previous Article in Journal
Isolation, Identification, and Characterisation of Degradation Products and the Development and Validation of a Stability-Indicating Method for the Estimation of Impurities in the Tolterodine Tartrate Formulation
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Sci. Pharm.
Volume 83
Issue 1
10.3797/scipharm.1408-08
scipharm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

A Stability-Indicating HPLC Method for the Determination of Fingolimod in Pharmaceutical Dosage Forms

by
Effat SOURI
1,*,
Mohammad ZARGARPOOR
1,
Siavash MOTTAGHI
1,
Reza AHMADKHANIHA
2 and
Abbas KEBRIAEEZADEH
3
1
Department of Medicinal Chemistry, Faculty of Pharmacy and Drug Design and Development Research Center, Tehran University of Medical Sciences, Tehran 141556451, Iran
2
Department of Human Ecology, School of Public Health, Tehran University of Medical Sciences, Tehran 1417613151, Iran
3
Department of Pharmacoeconomy and Pharmaceutical Administration, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2015, 83(1), 85-93; https://doi.org/10.3797/scipharm.1408-08
Submission received: 12 August 2014 / Accepted: 23 September 2014 / Published: 23 September 2014
Versions Notes

Abstract

Fingolimod is an immunosuppressive agent which is used for the prophylaxis of organ transplantation rejection or multiple sclerosis treatment. In this study, systematic forced degradation studies on fingolimod bulk powder were performed to develop a stability-indicating HPLC method. Separation of fingolimod and its degradation products was achieved on a Nova-Pak C8 column. The mobile phase was a mixture of potassium dihydrogenphosphate 50 mM (pH 3.0) and acetonitrile (45:55, v/v) at a flow rate of 1 ml/min. The proposed method was linear in the range of 0.125–20 μg mL−1. The within-day and between-day coefficients of variation were in the range of 0.6–1.2%. The developed method was successfully applied for the determination of the fingolimod amount in pharmaceutical dosage forms.
Keywords: Fingolimod; HPLC; Stability-Indicating; Stress degradation Fingolimod; HPLC; Stability-Indicating; Stress degradation

Share and Cite

MDPI and ACS Style

SOURI, E.; ZARGARPOOR, M.; MOTTAGHI, S.; AHMADKHANIHA, R.; KEBRIAEEZADEH, A. A Stability-Indicating HPLC Method for the Determination of Fingolimod in Pharmaceutical Dosage Forms. Sci. Pharm. 2015, 83, 85-93. https://doi.org/10.3797/scipharm.1408-08

AMA Style

SOURI E, ZARGARPOOR M, MOTTAGHI S, AHMADKHANIHA R, KEBRIAEEZADEH A. A Stability-Indicating HPLC Method for the Determination of Fingolimod in Pharmaceutical Dosage Forms. Scientia Pharmaceutica. 2015; 83(1):85-93. https://doi.org/10.3797/scipharm.1408-08

Chicago/Turabian Style

SOURI, Effat, Mohammad ZARGARPOOR, Siavash MOTTAGHI, Reza AHMADKHANIHA, and Abbas KEBRIAEEZADEH. 2015. "A Stability-Indicating HPLC Method for the Determination of Fingolimod in Pharmaceutical Dosage Forms" Scientia Pharmaceutica 83, no. 1: 85-93. https://doi.org/10.3797/scipharm.1408-08

Article Metrics

Back to TopTop